Jonathan Emeigh
Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Catalytic C–H Functionalization Methods, Immune Response and Inflammation, Renal Transplantation Outcomes and Treatments, Cytokine Signaling Pathways and Interactions, NF-κB Signaling Pathways
Most-Cited Works
- → Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies(2006)67 cited
- → Alkylation of Magnesium Sulfinates: A Direct Transformation of Functionalized Aromatic/Heteroaromatic Halides into Sulfones(2005)42 cited
- → Second-Generation Lymphocyte Function-Associated Antigen-1 Inhibitors: 1H-Imidazo[1,2-α]imidazol-2-one Derivatives(2004)34 cited
- → The discovery of thienopyridine analogues as potent IκB kinase β inhibitors. Part II(2009)32 cited
- Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.(1991)
- Interaction between FK 506 and cyclosporine in dogs.(1991)
- → Alkylation of Magnesium Sulfinates: A Direct Transformation of Functionalized Aromatic/Heteroaromatic Halides into Sulfones.(2005)